Evaluating Real-World COVID-19 Vaccine Effectiveness Using a Test-Negative Case-Control Design

Matthew W Reynolds, Alex Secora, Alice Joules, Lisa Albert, Emma Brinkley, Tom Kwon, Christina Mack, Stephen Toovey, Nancy A. Dreyer
doi: https://doi.org/10.1101/2022.01.06.22268726

Article Information

doi 
https://doi.org/10.1101/2022.01.06.22268726
History 
  • January 6, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Matthew W Reynoldsa,*,
  2. Alex Secoraa,
  3. Alice Joulesa,
  4. Lisa Alberta,
  5. Emma Brinkleya,
  6. Tom Kwona,
  7. Christina Macka,
  8. Stephen Tooveyb and
  9. Nancy A. Dreyera
  1. aIQVIA Real-World Solutions. 201 Broadway, Cambridge, MA 02139 USA
  2. bPegasus Research, Neuschwaendistrasse 6, 6390 Engelberg, Switzerland
  1. ↵*(corresponding author) Corresponding author full postal address: 3110 Fairview Park Drive, Suite 400, Falls Church, VA 22042. email: matthew.reynolds{at}iqvia.com
Back to top
Posted January 06, 2022.
Download PDF
Data/Code
Email
Evaluating Real-World COVID-19 Vaccine Effectiveness Using a Test-Negative Case-Control Design
Matthew W Reynolds, Alex Secora, Alice Joules, Lisa Albert, Emma Brinkley, Tom Kwon, Christina Mack, Stephen Toovey, Nancy A. Dreyer
medRxiv 2022.01.06.22268726; doi: https://doi.org/10.1101/2022.01.06.22268726
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area